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In recent years, there has been renewed interest in why people of lower Social-Economic status 
(SES) have worse health outcomes.  No matter which measures of SES (income, wealth or education) are 
used, the evidence that this association is large and pervasive across a variety of health outcomes such as 
mortality or morbidity is abundant 
(1, 2).  However, considerable debate remains about why the relation 
arises.  The traditional arguments— that the less well-to-do have access to less 
(3, 4) or lower quality 
(5) 
medical care or exhibit a stronger pattern of deleterious personal behaviors such as smoking and excess 
drinking—are seen as incomplete.  Recently, some intriguing theories have arisen that emphasizes long-
term impacts of early childhood or even inter-uterine environmental factors 
(6, 7) or the cumulative effects 
of prolonged exposures to individual stressful events 
(8).  While these may be important reasons for part of 
the SES health relationship, we investigate here another mechanism—the ability of individuals across 
different SES levels to comply with and maintain complex health regimens that are often prescribed to 
deal effectively with severe health problems. 
Many efficacious therapies now hold considerable promise in either delaying disease progression 
or mitigating health consequences.  However, the treatment regimens often require high quality and 
persistent patient self-management on a daily basis, and not all patients are equally adept at complying.  
In clinical practice, adherence rates can be as low as 20%, although the rate varies with complexity 
(9) and 
duration of therapy 
(10).  Compliance requires an understanding of medical necessity and an ability to 
select the most appropriate regimens.  It also requires a willingness to internalize the future costs of 
incomplete compliance.  Since education serves as a proxy for many of these personal traits, schooling 
may play a key role in explaining health outcomes for those with chronic illness, but this link has not 
been fully explored.   
This paper investigates the role of adherence to self-treatment regimens in creating and 
maintaining a steep gradient between an individual’s education and his health.  In our evaluation, we 
place special emphasis on the treatments for two diseases—HIV and insulin dependent diabetes.  Both 
represent diseases where recommended treatments are potentially highly efficacious.  However, they 
represent very different patient populations, and they differ in the role of patient judgment.  New 
antiretroviral therapies have been shown to reduce mortality in HIV+ patients 
(11).  While much more 
effective than previous methods of treating HIV, these treatments are complex—often involving over two 
dozen pills, tablets or capsules a day where the timing and order in which one takes pills must be carefully 
synchronized with meals and with each other 
(12). 
Successful management of diabetes typically involves fewer medications than HIV, but it 
requires more judgment about the appropriate level of glucose-medication titration.  Clinical trials 
consistently show that the complications from this disease can be avoided or deferred with tight glycemic 
control 
(13).  This makes extensive self-management important, including frequent monitoring of blood 
glucose levels, balancing dosages with food intake and physical activity, prevention and treatment of 
hypoglycemia, and regular consultation with health care providers.   
Despite these differences in treatment, we show that both HIV and diabetes demonstrate large 
differences in adherence by education groups, and these differences affect overall health status.  Further, 
we demonstrate that these differences are quite robust, appearing in both observational studies of patients 
with chronic illness and also in the regimented context of a randomized clinical trial.  Most importantly, 





To test the effects of education on HIV treatment regimens and outcomes, we use data from the 
HIV Cost and Services Utilization Study (HCSUS).  The study has been described in detail elsewhere 
(14). 
Briefly, the HCSUS employed a multi-stage national probability sample design to obtain a representative 
sample of adult patients in care.  For each sampled patient, the study attempted to conduct three rounds of 
interviews between January 1996 and January 1998.  We use data from the baseline (n=2864) and final 
round (n=2267), and identified patients receiving highly active antiretroviral therapy   2
(HAART) using the definition provided by Andersen et al. 
(15).  Their definition is based on 
recommendations published by the Centers for Disease Control and Prevention 
(16) and includes patients 
receiving various combinations of protease inhibitors, nucleoside reverse transcriptase inhibitors, and 
non-nucleoside reverse transcriptase inhibitors.   
In the final round, patients were asked to list every HIV medication they were taking, and to 
report for each medication, how many days in the past week they adhered to its prescribed regimen.  
Given the potential consequences of non-compliance, we consider a patient adherent only if—for every 
medication taken—he reported taking it for seven of the past seven days.  This approach to measuring 
adherence has been significantly associated with viral load 
(17).  To assess the impact on health, we 
primarily consider changes in general health.  We rely on self-reported general health status as measured 
on a five point ordinal scale from excellent to poor.  This scale is a widely accepted measure of general 
health status 
(18) and is known to be highly predictive of future objectively measured health outcomes 
(19). 
For diabetes, we utilize two important surveys—the Health and Retirement Survey (HRS) and the 
Diabetes Control and Complications and Trial (DCCT).  HRS is a high quality general-purpose 
longitudinal social science survey while the DCCT is a randomized perspective clinical diabetes trial.  
These studies have complimentary strengths that combined help elucidate the critical role of self-
adherence in diabetes treatment.  HRS is a national probability sample of 12,650 men and women born 
between January 1, 1931 and December 31, 1941 (ages 51-61 in 1992) and their spouses.  The overall 
response rate was 80%.  HRS’s main objective is to monitor interactions between economic status and 
health outcomes during and after the transition to retirement.  Follow-ups of HRS respondents were 
fielded at two-year intervals, and the first four waves of the survey are used here.  The survey included 
questions on demographics, income and wealth, family structure, employment, and cognition.  Questions 
were asked in each wave about self-reports of general health status, the prevalence and incidence of many 
chronic conditions, and types of medical treatments followed.  Individuals with diabetes are asked if they 
are taking any medication that they swallow and whether they were using insulin shots or a pump. 
The DCCT was a randomized prospective clinical trial examining the effectiveness of intensive 
treatment of diabetes mellitus in preventing or delaying complications from disease 
(13).  Between 1983 
and 1989, the DCCT enrolled a total of 1,441 patients aged 13 to 39 years who had insulin-dependent 
diabetes mellitus for one to fifteen years; and no hypertension, hypercholesterolemia, or severe diabetic 
complications or medical conditions.  These patients were randomized to either an intensive or 
conventional therapy and were followed through April 1993.  Such randomization has the traditional 
benefit of measuring the effectiveness of a new treatment. Since the assignment to treatment was random 
by education groups, it allows us to estimate the differential impact of an enforced effective treatment 
across patients in different SES groups.  It is that aspect of randomization that we utilize in our analysis.  
Standard therapy consisted of one or two injections of insulin per day with daily self-monitoring 
of blood glucose, a schedule of clinic visits, and monitoring procedures every three months.  Intensive 
therapy included insulin injections three or more times daily or an external pump.  The dosage was 
adjusted based on the results of self-monitoring at least four times per day, dietary intake, and anticipated 
exercise.  Subjects were seen weekly at the clinic until a stable treatment program was achieved and at 
least monthly thereafter.  Telephone contact was made daily for the first week and weekly thereafter. 
 
Analysis of Treatment Adherence   
We used probit regression to assess the impact of years of schooling—categorized as 12, 13-15, 
or 16 or more years of schooling with less than 12 years of schooling the excluded category—on 
adherence to HAART as measured by whether a patient took his medication properly for seven of the past 
seven days and health outcomes.  Probit regression assumes the distribution of the underlying model error 
is normal, and is well suited to models with categorical responses 
(20).  It is very similar to logistic 
regression when the response variable is binary, but it extends more readily to responses with more than 
two possible outcomes—our situation for changes in health.  The models also control for baseline 
measures of general health (excellent or very good, good, fair, or poor); baseline measures of self-
reported lowest CD4+ lymphocyte count from patient self-reports (less than 50 cells per mm
3, 50-199   3
cells, 200-499 cells, and 500+ cells), health insurance status, census region, age, race, sex,  exposure route 
(intravenous drugs or homosexual male), and income.   
For diabetics in the HRS, we classified treatment patterns over the waves as "good" or "bad" 
regimens and ran a probit regression to investigate how years of schooling (categorized as for HIV) 
affected treatment.  The regression included demographic controls (female, black, and Hispanic), and 
birth cohort (post 1937, 1935-1937, and pre 1937).  Marital status and gender interactions where included 
to test whether marriage conferred some benefit in terms of better treatment.  We estimated the model 
with and without the Wechsler Adult Intelligence Score (WAIS), a measure of higher-level reasoning to 
examine whether cognitive ability mediated adherence differences by education group. 
Several simple rules were used in making the determination of “good” or “bad” in the HRS.  If a 
respondent maintained the same regimen over all three waves—taking nothing, taking medication only, 
taking insulin only, or taking both—the treatment was considered good.  These regimens accounted for 
the majority of good regimens.  The remaining good behaviors included patients who started on 
medication but ended up on insulin, under the presumption the disease had progressed.  Bad behaviors 
typically took two forms.  In the first form, patients stopped their treatment—i.e., they report taking either 
medicine or insulin in one wave, and then reporting taking neither in a subsequent wave.  Other patients 
reported switching from one treatment to another and then back to the original treatment—for example, 
taking insulin in one wave, then medication in a second wave, and then back to insulin. Finally, some 
poor treatment patterns, which occurred infrequently, consisted of patients who added a second regimen 
to their initial treatment; for example, adding a medication to an insulin regimen or vice-versa.  We 
conducted sensitivity analyses by examining the association between education and good behavior under 
alternative definitions of “good”.  Our analyses were not sensitive to these changes.  
 
Analysis of Health Outcomes 
A basic issue is whether non-adherent or poor health maintenance behaviors have any impact on 
subsequent health outcomes.  For HIV, we consider the impact of adherence on morbidity, since it is 
already well established that adherence affects viral load 
(17) and hence mortality 
(21).  For morbidity, we 
recorded whether patients’ self-reported health got worse, stayed the same, or improved between the 
baseline and final round.  This change in health status was then related to treatment (and adherence) by 
including two variables that measure whether the patient received HAART and whether the patient 
adhered to HAART.  We also included schooling and the other factors used in the adherence analysis. 
For diabetics in HRS, we examined the change in self-reported health between the first and forth 
round of HRS among those who had been diagnosed with diabetes by the baseline round of the survey.  
Using these two reports of self-rated health measured eight years apart, we estimated an ordered probit 
again recording whether self-reported health got worse, same the same, or improved.  A variable 
indicating whether the respondent engaged in poor health maintenance behavior between these waves was 
included in the model.  Since change in health outcome is naturally ordered and categorical, ordered 
probit estimation methods were used for both diseases 
(20).  In DCCT, we measure health outcomes with a 
more objective measure using hemoglobin A1c (glycosolated hemoglobin). This laboratory test measures 
the amount of sugar binding to the hemoglobin over the last two to four months with higher levels 





Table 1 illustrates the difference in patient-intensive treatment and some selected health outcomes 
across educational groups for the third round.  Our measure of SES—years of schooling—is related both 
to the fraction using HAART and the fraction who adhere to the regimen.  For example, 68% of college 
graduates use HAART, but only 54% of high school dropouts do so.  Similarly, 57% of college graduates 
always adhere to their treatment regimens, while only 37% of high school dropouts do so.  For these two 
adherence measures, all education groups above high school are statistically different than the lowest   4
education category.  The consequence of lower use of HAART and lower levels of adherence by the less 
educated is suggested by the differences in general health; the less educated are much more likely to 
report poor general health.  Finally, changes in CD4 cell counts—a key measure of immune response 
(with higher levels meaning better function)—between baseline and second follow-up also vary 
systematically by education group. 
Table 2 summarizes our analysis of the relationship of education on adherence to HAART and its 
subsequent impact on health.  Even after controlling for disease status, insurance, income, and other 
factors, more educated patients are more likely to adhere to therapy.  The magnitude of this effect is not 
trivial.  For example, the estimated effect of college education relative to high school dropouts (0.308) is 
on par with the effect of being black or female, two groups often cited in the health disparities literature. 
It is important to note as well that education and not income is related to adherence behavior so that the 
impact of education on adherence is not operating through economic resources.   
Second, strict adherence to the HAART therapeutic regimen and not simply being a HAART user 
was absolutely critical in achieving better health outcomes.  The last three columns of Table 2 show that 
among those taking HAART, only strict adherence improved their self-reported health status.  
Importantly, education does not have a significant impact on health after we control for adherence. That 
is, the effect of education on health operates entirely through adherence.  Moreover, there is also a strong 
linear relationship between linear years of schooling and mortality, which is substantially mediated by 
treatment adherence.  In fact years of education is no longer a significant predictor of mortality once we 
control for treatment and adherence.  Like our results for general health, we find that it is only treatment 
adherence that matters—treatment alone is not beneficial. 
 
Diabetes—Results from a Population-based Survey  
Table 3 shows general health status at baseline for all HRS respondents (top panel) by education 
level.  Consistent with many studies, the steepness of the HRS health gradient is impressive—only one-
third of those who did not graduate from high school reported themselves in either excellent or very good 
health compared to almost three-quarters of college graduates.  Similarly, 36% of those in the lowest 
education category were reported in either fair of poor health compared to only six percent in the highest 
education group.  Not surprisingly, the general frequency of bad health increases dramatically in the 
second panel of Table 3 that is confined to diabetics.  Even among diabetics, the health gradient with 
schooling remains large—two-thirds of those who were not high school graduates self-reported in either 
fair or bad health compared to only about one-fifth of diabetics who were college graduates.  This pattern 
suggests that severity of disease at baseline also declines with years of schooling.   
There also exists a strong association between years of schooling and the overall prevalence of 
diabetes at baseline as well as with the new onset of this disease during the first four waves of the panel.  
For example, 12.4% of respondents who had 0-11 years of schooling suffered from diabetes at baseline, 
twice the rate observed among college graduates.  Similarly during the first four waves of this survey, 
7.9% of those with 0-11 years of schooling were newly diagnosed with diabetes, once again twice the rate 
of new onsets among college graduates. 
Table 4 examines adherence to medical treatment among diabetics.  For both medication and 
insulin, we divided respondents into three types—those who were always on that treatment, those who 
were never on the treatment, and those who were irregularly on the treatment.  Within either type of 
treatment, there exists a steep negative gradient with years of schooling for switching behavior.  For 
example, 48% of those with 0-11 years of schooling were classified as switchers in medication compared 
to 23% among college graduates.  Similarly, 23% of diabetes with 0-11 years of schooling were classified 
as switchers for the use insulin or pump compared to only 16% of college-graduated diabetics.  
Table 5 considers the impact of “bad” behavior on health status changes.  Over an eight-year time 
frame, self-reported health among diabetics is less likely to deteriorate the higher the education of the 
respondent and among female diabetics, while minorities (African-Americans and Latinos) are more 
likely to experience a worsening health.  Age effects are not strong because this sample is limited to 
respondents within a narrow age range (51-61 at baseline).  Most importantly, those who followed a   5
’poor’ health regimen were much more likely to experience a negative health outcome.  Once again, the 
magnitude of the health deterioration associated with a poor health regimen is not trivial. This effect is as 
large as that estimated as the difference between having less than a high school degree and being a college 
graduate and is on a par with the magnitude of the gender, race and ethnic effects.  
  What types of people follow poor health maintenance regimens?  The results of our probit 
analysis of following a poor health regimen are summarized in Table 6.  There appear to be no 
statistically significant gender, age, race, or ethnic differences in this behavior.  However, we do find a 
statistically significant interaction between changes in marital status and being a male.  Men who went 
from married to single were significantly less likely to maintain a good health regimen, suggesting that 
wives serve a protective role in helping men adhere to a good health regimen.  Married men appear to 
offer no parallel protection for their wives.  In supplementary analysis, we tested whether the significance 
of a wife varied by education by interacting the married-single variables with the 0-11 education group.  
These results indicate that the presence of a wife was more beneficial for more educated men, an 
indication that this is another advantage held by the more educated.  
We estimate that more schooling reduces the likelihood of following a poor health regimen.  The 
second model in Table 6 attempts to address the question of why education might matter.  This model 
adds the respondent’s Wechsler Adult Intelligence Score (WAIS), measured in the baseline wave of the 
survey.  This score is not only statistically significant, but in fact fully captures the education effects, as 
education no longer has any statistically significant independent effect. WAIS is a test that is geared to 
higher-level reasoning.  The WAIS similarities subtest requires verbal concept formation, abstract 
reasoning abilities, flexible thinking, and inductive reasoning 
(22).  Other tests available in the HRS related 
to memory ability were also included in this model but they had no influence on adherence and did not 
affect the education gradient.  The source of the association with SES does not appear to be economic 
resources, but rather the individual's ability at higher-level reasoning.  It would be important in future 
research to expand the cognitive measures beyond the WAIS score available in HRS.  While intriguing, 
our findings regarding cognitive ability should be viewed as suggestive until replicated in other studies. 
 
Diabetes—Results from a Randomized Clinical Trial 
In Table 7 we compare the self-management behaviors of the DCCT sample at baseline by 
education status.  Across several dimensions, these patterns indicate that the more educated were more 
successful in monitoring and managing their disease.  For example, the more educated were less likely to 
miss an insulin injection, but were more likely to follow their monthly insulin regimen and to self-test 
their blood or urine levels on a monthly basis.  In addition, those with more a college education or more 
spend more minutes per week exercising at a moderate or intensive level, and were less likely to smoke.  
This clinical trial, which imposes a rigid treatment regimen on those in the control group, is 
known to have produced improved glycemic control 
(13).  Our hypothesis is that imposing this intensive 
regime will have a larger impact on the less educated participants due to poorer self-maintenance in 
normal circumstances.  This is a very stringent test of our hypothesis.  Even in the DCCT there is a 
relatively homogenous treatment regimen for those in conventional therapy; they need to attend quarterly 
physical exams, meet with their treatment team, and of course, they are being treated in the same settings 
regardless of educational status.  The patients are also highly motivated 
(23).  Thus, we expect the DCCT 
to understate the true effect of educational differences in self-maintenance on disease outcomes.   
Table 8 considers the implications of being included in the rigid enforced regimen by examining 
differences in glycemic control across education groups in both the control and treatment samples.  In the 
control group the primary endpoint of glycosylated hemoglobin shows a larger increase among the 
secondary school participants than those with at least some college education.  This result is consistent 
with those found in the HRS that indicates that following ‘normal’ treatment regimen, health outcomes of 
the less educated diabetics will deteriorate at a more rapid rate.  Serum blood glucose levels measured in 
the morning tell a similar story.   
However, in the lower panel of Table 8, we see that there is very little gradient in outcome 
changes over time across educational group for those in the intensively treated arm. The impact of the   6
enforcing a common treatment regime can be obtained by subtracting what normally would occur  (the 
control sample) with what took place under an enforced treatment regimen (the treatment sample).  These 
results, which are listed in the final row of Table 8, demonstrate that the enforced treatment had a much 
larger impact on less educated patients.  This treatment effect is statistically significant.  We also 
examined whether this treatment effect of the enforced behavioral regimen could be due to changes in 
smoking, physical exercise, both of which were strongly related to education at baseline (see Table 7). 
We estimated a series of models (not shown) to determine whether changes in smoking, exercise, or 
weight change were different in the treatment and control groups, and whether such differences emerged 
by education groups.  There were no statistically significant differences between the treatment and control 
group at any education level in changes in smoking behavior or in vigorous exercise.  There was actually 
a slight weight gain (3 lbs) among the less-educated treatment group compared to the less-educated 
controls.  Therefore, changes in personal behaviors that are more conducive to better health outcomes 
appear not to be the reason for the improved health of the less-educated group in the treatment arm.  
Rather, the source of the improvement lies instead in better adherence to a medically superior regimen.   
 
DISCUSSION 
We have studied the ability of individuals across different SES levels to comply with and 
maintain complex health regimens that are often proscribed to deal effectively with severe health 
problems.  For both diseases, the ability to maintain a better health regimen is an important independent 
determinant of subsequent health outcomes.  Since this ability varies across schooling groups, self-
maintenance is an important reason for the very steep SES gradient in health outcomes.  This finding is 
quite robust to the population and the measure of health improvement.  
We found similar results on the importance of adherence for diabetics and its relation to SES in 
two quite different types of studies.  Containing rich background detail on respondents, HRS is a large 
representative national probability sample that easily generalizes to the population.  HRS suffers from a 
lack of clinical detail and self-assignment of individuals to their treatment regimens.  In contrast, the 
DCCT is a clinical trial with random assignment with much more detail on objective clinical outcomes 
associated with diabetes including laboratory measures of glycemic control.  Yet, the ability to generalize 
from clinical trials is sometimes questioned since the participants are thought to be highly motivated.  We 
believe that the similarity of our results on adherence in these two different types of studies adds great 
weight to the importance of adherence and its role in creating a SES health gradient. 
A question arises whether our results generalize to other illnesses.  HIV is an extremely serious 
illness with a quite complicated treatment and a relatively low prevalence in the population.  But we also 
looked at diabetes, which is often considered the prototype for chronic disease management.  Conditions 
where treatment requires continual patient judgment about when and how much to medicate, and the type 
of medicine, could show similar gradients.  An example would be asthma, where patients need to respond 
to environmental factors and use drugs to manage acute symptoms.  There are also analogies to treatments 
such as hypertension, although the differential impact of education may be muted as the drug regimen is 
not as complicated and the consequences of non-compliance are less severe. 
Our research also suggests several explanations for why education matters.  Good adherence to a 
treatment regimen requires several attributes that may be strongly related to education.  First, a patient 
must be able to comply with physician orders by first comprehending what is being prescribed, and then 
regimenting one's daily routine to execute it.  Education certainly helps comprehension; and it may assist 
regimentation by teaching patients how to allocate time during the day.  Second, most medical 
recommendations require independent judgment and some accommodation by the patient.  In Type 1 
diabetes, a patient needs to consistently monitor their levels of blood glucose and titrate their insulin 
intake accordingly.  The risk of acute hypoglycemia—and its attendant symptoms—must be balanced 
against the less immediate reduction in risk of long-term complications.  Similarly, diabetics must learn 
how their body responds to insulin in many situations, and adjust their future regimens accordingly. For 
HIV, drugs must be timed with eating, fat content of meals, and fluid intake.  Immediate side effects such 
as diarrhea, fatigue, nausea and vomiting must be balanced against longer-term mortality improvements.    7
Education could train people to be better at making these judgments, by making them better at obtaining 
and processing information like fat content.   
On a positive note, our results suggest differential health outcomes across SES level due to 
different abilities to self-manage a demanding behavioral regimen are amenable.  Our HRS results 
demonstrate that the presence of a wife can assist in maintaining adherence behavior.  Second, our results 
from the DCCT indicate that imposing an enforced regimen combined with intensive patient 
monitoring—e.g., weekly phone reminders—eliminates the more negative health outcomes of the less 
educated.  As Fink 
(24) notes, there is no universal treatment regimen for a standard patient.  Our results do 
not imply prescribing less effective—but less complicated—therapy to the less educated.  Rather, 
providers must assess the ability and willingness of a patient to comply with proscribed treatment, and 
manage treatment accordingly.  Less educated patients would benefit more from frequent follow-up, 
simpler drug regimens, and clear instructions about how to comply and the consequences of non-
compliance.  Medical practice acknowledges that not all patients are alike in the nature of their disease.  
But neither are they the same in their ability to self-manage their treatment regimens unassisted.   
Technology also plays a critical role in explaining health disparities.  If medical science continues 
to evolve effective but complicated drug regimens, this may exacerbate health outcome disparities across 
patients with different levels of education unless we recognize that not all patients are equally adept at 
adherence.  Research to encourage patients with low SES to better adhere to currently available 
treatments might be effective in improving the health of the millions of Americans with chronic disease.  
In the case of diabetes, research into better insulin-delivery devices might benefit only some patients, 
while other potential treatments such as stem cell transplantation might reduce disparities.  
   8
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Table 1 
Educational Differences in HIV-related Treatment and Outcomes 
 
  Using  Using HAART  Fair or Poor  Change in 
Years of  HAART  And Adhering  General Health  CD4 Cell Count 
Schooling (%)  (%)  (%) (cells  per  mm
3) 
0-11 54.2  37.1  31.4 30 













   ***p<.01, 
**p<.05, 
*p<.10 for a test of equality with the 0-11 years of education subgroup. 
   Note:  The first two columns show percentages using HAART and adhering to HAART at second follow-up in 
HCSUS.  The third column shows the fraction at second follow-up reporting fair or poor general health, and the 
fourth column shows the change in CD4 cell counts from baseline to second follow-up.   
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Table 2 
Predictors of Adherence to HIV Treatment and Subsequent Changes in Health 
 
     
Adhering to HAART 
treatment:     Change in general health:
        β    Std. Error   p     β Std.  Error  p 
Using HAART  ——       0.126 0.064  0.048
Using HAART and adhering  ——       -0.191  0.064  0.003
Education (excluded=0-11 years):             
 12 years  0.041 0.102  0.690  0.028 0.072  0.691
 13-15 years  0.183 0.102  0.073 -0.035 0.073  0.633
 16+ years  0.308 0.122  0.012 -0.088 0.086  0.305
Black  -0.332 0.087  0.000 -0.018 0.061  0.770
Female  -0.182 0.102  0.074  0.196 0.071  0.006
   Note:  Models also control for age, exposure route, census region of residence, CD4 count at baseline, self-
reported general health at baseline, and insurance status; full results are shown in the Appendix.  The first three 
columns show probit regression estimates for adhering to HAART (among HAART users only).  The second three 
columns show coefficient estimates from an ordered probit for whether general health improved, stayed the same, or 
got worse between baseline and second follow-up.  Positive estimates in the ordered probit for change in health 
status indicate greater likelihood of condition worsening.  
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Table 3 
Self- Assessed Health Status for All HRS Respondents and Those with Diabetes at Baseline 
A. All  Respondents 
  Years of Schooling 
 ________________________________________ 
 
Baseline Health Status     0-11  12  13-15  16+ 
Excellent     12.0  23.2  29.5  39.2 
Very good      20.7  32.8  34.7  35.4 
Good     31.4  27.0  25.1  20.1 
Fair     22.2  12.0  8.4  3.8 
Poor     13.7 5.1  2.4  1.7 
 
B.  Respondents with Diabetes 
Excellent     2.5  3.7  10.2  8.2 
Very good      12.1  14.1  18.6  30.0 
Good     19.2  37.4  40.8  41.9 
Fair     38.5  29.2  23.0  14.7 
Poor     27.7  15.4  7.4  5.2 
   Note:  Sample-Health and Retirement Survey.  51-61 years old in 1992. 
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Table 4 
Patterns of Treatment Among Diabetics 
Education Always  Never  Switches 
A. Take Oral Medication 
0-11 32.4  19.6  48.0 
12 30.6  30.9  38.4 
13-15 26.6  36.2  37.1 
16+ 40.7  36.0  23.3 
 
B. Use Insulin or Pump 
0-11 21.4  56.1  22.5 
12 20.5  57.2  22.3 
13-15 15.4  63.5  21.1 
16+ 19.4  65.1  15.5 
   Note:  Sample is respondents with diabetes at baseline in the Health and Retirement Study and 51-61 years old 
in 1992 (N=869).  Rows sum to 100%.  Patients with less education are more likely to switch treatment regimens 
over the course of the study. 
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Table 5 
Predictors of a Change in General Health Status Between Wave 1 and Wave 4 
 
   Change in General Health: 
   β  Std. Error  p 
Years of Schooling (excluded=0-11 years):     
   12 years  -0.164  0.101  0.105 
    13-15 years  -0.248  0.127  0.051 
   16 or more years  -0.199  0.142  0.160 
       
Poor Self-Maintenance Behavior  0.246  0.102  0.016 
Female -0.099  0.084  0.240 
Black 0.229  0.095  0.016 
Hispanic 0.357  0.131  0.006 
   Notes:  Model also controls for general health at baseline and birth year; full model results are shown in the 
Appendix.  Sample is respondents with diabetes at baseline in the Health and Retirement Study and 51-61 years old 
in 1992 (n=869).  Treatment regimens classified as ‘poor’ are associated with decrements in general health between 
Waves 1 and 4. Changes are estimated using an ordered probit (got worse, stayed the same, got better), so positive 
coefficient estimates indicate greater likelihood of worsening general health between waves.   14
Table 6 
Predictors of Poor Self-Maintenance Behavior 
 
   Without WAIS score:     With WAIS score: 
   β  Std. Error p     β  Std. Error  p 
Years of Schooling (excluded=0-11 years):     
   12 years  -0.240 0.121  0.047 -0.151  0.124  0.224
   13-15 years  -0.284 0.152  0.061 -0.142  0.160  0.373
   16 or more years  -0.303 0.168  0.072 -0.065  0.185  0.724
Female 0.083 0.109  0.442 0.094  0.109  0.388
Black 0.110 0.115  0.338 0.011  0.120  0.927
Hispanic 0.013 0.158  0.933 -0.045  0.159  0.780
Married Waves 1 and 4  -0.078 0.12  0.517 -0.076  0.120  0.526
Married Wave 1 and Not Married Wave 4 0.492 0.304 0.106 0.546  0.305  0.073
Not Married Wave 1 and Married Wave 4 0.071 0.426 0.868 0.083  0.437  0.849
Female, Married Wave 1 & Not Married 
Wave 4  -0.580 0.378 0.126 -0.601  0.378  0.112
WAIS Score   ----      -0.057 0.020  0.004
   Note:  Models also control for birth cohort and missing WAIS score; full results are shown in the Appendix.  Sample 
is respondents with diabetes at baseline in the Health and Retirement Study and 51-61 years old in 1992 (n=869).  Table 
shows results from a probit regression of whether the patient had a  ‘poor’ treatment regimen over successive waves.     15
 
Table 7 
Educational Differences in Treatment Adherence (at DCCT baseline) 
 
  College grad/  HS degree/ 
Postgrad  Some  some 
Measure of adherence  degree  college  secondary 
No. of times self-monitored blood glucose per week  8.8      7.7      6.7     
Missed insulin injection at least once in past month (%)  4.3      6.0      9.2     
Did not follow insulin regimen at least once in past month (%)  15.7      25.2      26.6     
Did not self-test blood or urine at least one day in past month (%)  66.1      74.1      77.2     
Minutes of very hard exercise per week  58.1      49.6      19.7     
Currently smoking cigarettes (%)  16.5      19.2      40.8     
   Note: Sample is non-student Type 1 diabetics from the DCCT (n=985).  Adherence measures are from 
self-reports at baseline.  16
 
Table 8 
Educational Differences in Treatment Impact for Diabetics 
 
  Glycosolated Hemoglobin: 
  Postgraduate College grad/  HS degree/ 





Conventional Therapy Only (n=495)       
 Baseline  8.42   8.76    8.96  
 End-of-study  8.88  9.08     9.59   
  Difference 0.46   0.32     0.63  
 
Intensive Treatment Only (n=490) 
    
 Baseline  8.04   8.86     8.93  
 End-of-study  7.18  7.30     7.43   
  Difference -0.85   -1.56   1.51  
      
Treatment Effect
#  -1.31   -1.88*   2.14**  
   *p<.10; 
**p<.05
 
   #Treatment effect is the improvement in glycemic control among the intensive treatment group relative to 
conventional therapy.  Average follow-up period was 72 months.  Significance levels are for a test of equivalence 
with the postgraduate category and control for duration in study, gender, marital status, and age.  Intensive 
treatment was more efficacious for the less educated.   17
APPENDIX 
Full Model Results for Table 2 
(HIV Treatment at Wave 1 and Change in General Health from Wave 1 to Wave 3) 
      Adhering to HAART treatment:  Change in general health: 
      b  Std. Error  p  b  Std. Error  p 
Using HAART  ——      0.126  0.064  0.048 
Using HAART and adhering  ——      -0.191  0.064  0.003 
Education (excluded=0-11 years): 
  12  years    0.041 0.102  0.690 0.028  0.072  0.691 
  13-15  years    0.183  0.102 0.073  -0.035 0.073 0.633 
  16+  years    0.308  0.122 0.012  -0.088 0.086 0.305 
Age     -0.021 0.032  0.508 0.045  0.020  0.026 
Age  squared  0.431  0.377 0.254  -0.442 0.238 0.063 
Black   -0.332  0.087 0.000  -0.018 0.061 0.770 
Female    -0.182 0.102  0.074 0.196  0.071  0.006 
Used  intravenous  drugs  0.200 0.116  0.086 0.135  0.082  0.098 
Male who has had sex with men  0.091  0.096  0.345  0.096  0.069  0.166 
Census region (excluded=West): 
  Northeast    0.298  0.108 0.006  -0.179 0.077 0.020 
  South    0.343  0.095 0.000  -0.142 0.066 0.032 
  Midwest    0.200  0.117 0.087  -0.032 0.089 0.723 
Baseline CD4 count (excluded<50): 
  500+   -0.383 0.201  0.056 0.021  0.109  0.850 
  200-499    -0.239  0.094 0.011  -0.152 0.071 0.031 
  50-199   -0.095  0.090 0.291  -0.064 0.069 0.358 
Baseline health (excluded=Poor): 
  Excellent/Very  Good  0.294 0.139  0.034 2.063  0.113  0.000 
  Good   0.200 0.140  0.154 1.100  0.113  0.000 
  Fair    0.022 0.139  0.876 0.663  0.112  0.000 
Insurance (excluded=none): 
  Medicaid    0.009 0.123  0.942 0.280  0.083  0.001 
  Medicare    0.139 0.151  0.357 0.301  0.108  0.005 
  Private  Insurance  0.002 0.126  0.985 0.134  0.086  0.118 
   Medicaid and Medicare  0.099  0.133  0.454  0.195  0.093  0.035 
Income  
 2
nd  Quartile    0.021 0.115  0.855 0.084  0.077  0.273 
 3
rd  Quartile    -0.017  0.114 0.880  -0.067 0.080 0.400 
 4
th  Quartile    0.077  0.138 0.579  -0.141 0.096 0.142 
   Notes:  See Table 2.   18
APPENDIX (con't) 
Full Model Results for Table 5 
(Change in General Health Status Between Wave 1 and Wave 4) 
      
   Change in General Health: 
   β  Std. Error  p 
Years of Schooling (excluded=0-11 years):     
   12 years  -0.164  0.101  0.105 
   13-15 years  -0.248  0.127  0.051 
   16 or more years  -0.199  0.142  0.160 
 
Wave 1 Respondent Health (excluded=Good): 
   Excellent  1.665  0.323  <.001 
   Very Good  0.756  0.135  <.001 
   Fair  -0.633  0.104  <.001 
   Poor  -1.474  0.128  <.001 
 
Poor Self-Maintenance Behavior  0.246  0.102  0.016 
Birth year (excluded=before 1935): 
   1935-1937  -0.131  0.107  0.222 
   1938+  0.141  0.094  0.134 
Female -0.099  0.084  0.240 
Black 0.229  0.095  0.016 
Hispanic 0.357  0.131  0.006 
   Notes:  See Table 5. 
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APPENDIX (con't) 
Full Model Results for Table 6 
(Poor Self-Maintenance Behavior) 
 
   Without WAIS score:  With WAIS score: 
   β  Std. Error  p  β  Std. Error  p 
Intercept -0.774  0.156  <.0001  -0.558  0.178  <.0001 
Years of Schooling  
       (excluded=0-11 years):     
   12 years  -0.240  0.121  0.047  -0.151  0.124  0.224 
   13-15 years  -0.284  0.152  0.061  -0.142  0.160  0.373 
   16 or more years  -0.303  0.168  0.072  -0.065  0.185  0.724 
Birth year (excluded=before 1935):     
   1935-1937  0.213  0.128  0.096  0.231  0.129  0.073 
   1938+  0.101  0.116  0.384  0.122  0.117  0.294 
Female 0.083  0.109  0.442  0.094  0.109  0.388 
Black 0.110  0.115  0.338  0.011  0.120  0.927 
Hispanic 0.013  0.158  0.933  -0.045  0.159  0.780 
Marital Status: 
  Married Waves 1 and 4  -0.078  0.12  0.517  -0.076  0.120  0.526 
  Married Wave 1 and Not Married Wave 4  0.492  0.304  0.106  0.546  0.305  0.073 
  Not Married Wave 1 and Married Wave 4  0.071  0.426  0.868  0.083  0.437  0.849 
  Female & Married Wave 1 &  
      Not Married Wave 4  -0.580  0.378  0.126  -0.601  0.378  0.112 
Proxy Respondent  -0.267  0.313  0.394  -0.241  0.310  0.438 
WAIS Score   ----     -0.057 0.020  0.004 
WAIS  Score  missing  ----       0.258 0.172  0.135 
   Note:  See Table 6. 
 
 